Condition: Mycobacterium Avium Complex Pulmonary Disease · Sponsor: Bin Cao
The goal of this clinical trial is to learn if cordyceps sinesis capsule (Bailiing Capsule) works to prevent the recurrence of microbiologically cured mycobacterium avium complex pulmonary disease in adults. The main questions it aims to answer are: Does cordyceps sinesis capsule (Bailiing Capsule) prevents the recurrence of mycobacterium avium complex pulmonary disease in adults? Researchers will compare cordyceps sinesis capsule (Bailiing Capsule) to a placebo (a look-alike substance that contains no drug) to see if cordyceps sinesis capsule helps to prevent the recurrence of mycobacterium avium complex pulmonary disease. Participants will: Take cordyceps sinesis capsule (Bailiing Capsule) or a placebo (a look-alike substance that contains no drug) for 12 months, both are administered every day. Visit the clinic once every 3 months for checkups and tests. Take online questionnaires every month.
This description comes directly from the study's public registry record.
Siwei Gu, M.D. · +86 010 84205566 · orbitline2@gmail.com
Always discuss trial participation with your own doctor first.
| Anhui Chest Hospital | Hefei, Anhui, China | Recruiting |
| Beijing Chest Hospital, Capital Medical University | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| China-Japan Friendship Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Guangzhou Chest Hospital | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Jiangxi Chest Hospital | Nanchang, Jiangxi, China | Recruiting |
| Shanghai Pulmonary Hospital | Shanghai, Shanghai Municipality, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07174076